foto london banner.jpg

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

[REPORT] Trends and Truth in Life Sciences Investm...

We are delighted to announce the launch of Biotech and Money's Investor Per...

Read More

7 questions with Isobel Finnie, Europe and UK pate...

Biotech and Money recently caught up with Europe and UK patent attorney Iso...

Read More

Further additions to the lineup of presenters at t...

We’re delighted to announce further additions to the lineup of presenters a...

Read More

Updated Attendee list for Biotech and Money's Awar...

Over that last week we've added a couple of dozen new names to the growing ...

Read More

Biotech and Money Assembly and Awards Gala Dinner ...

Biotech and Money Assembly and Awards is a 300 person Gala Dinner celebrati...

Read More

Investment Philosophies and Fundamental Trends

Biotech and Money had the opportunity to speak to Andy Smith CIO of Mann Bi...

Read More

[ONES TO WATCH] Life Science showcases announced a...

At the 2nd annual Biotech and Money London conference, we’re all about givi...

Read More

ISSUE 8, 2016 Drugs & Dealers Magazine Released

Biotech and Money are pleased to announce the release of the latest Drugs &...

Read More

ADVANCED THERAPIES: NO LONGER JUST HYPE?

10-12 years ago everyone was talking about cell therapy and regenerative me...

Read More

Attracting investment from a leading EIS fund

We talk to CEO David Venables off the back of Synpromics securing £2.1m EIS...

Read More

Outlook, investment & challenges facing UK CEOs - ...

During the recent HealthEx London forum at One George Street, Westminster, ...

Read More

Searing temperatures and hot debate at HealthEx Lo...

On the hottest day on record for over 165 years, 30 CEOs and CFOs from many...

Read More

Add Your Response